Frederick, MD, United States of America

Ira Daar

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ira Daar. Retrieved from https://idiyas.com/inventor/ira-daar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ira Daar

Introduction

Ira Daar is a notable inventor based in Frederick, MD (US), recognized for her significant contributions to cancer treatment. With a focus on pharmaceutical compositions, she has developed innovative methods aimed at inhibiting cancerous cell growth.

Latest Patents

Ira Daar holds a patent for "Methods for the treatment of cancer." This patent describes a pharmaceutical composition that includes an effective amount of paclitaxel or its derivatives, combined with an active agent that inhibits cancerous cell growth by affecting the mammalian cell cycle during the G1 or S-phase. This innovative approach aims to provide effective treatment options for cancer patients.

Career Highlights

Ira Daar works for the United States of America as represented by the Department of Health. Her role in this esteemed organization highlights her commitment to advancing medical research and improving health outcomes through innovative solutions.

Collaborations

Ira has collaborated with esteemed colleagues such as George F. Vande Woude and Nicholas Schulz, contributing to a collaborative environment that fosters innovation in cancer research.

Conclusion

Ira Daar's work exemplifies the impact of innovation in the field of cancer treatment. Her dedication to developing effective pharmaceutical compositions showcases her commitment to improving patient outcomes and advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…